#DelveInsight
LightNews LightNews
newsen.bsky.social
The Myelodysplastic Syndrome Market's Future: Anticipated Growth and Innovations from 2026 to 2036#None#DelveInsight#innovative_therapies#Myelodysplastic_Syndrome
The Myelodysplastic Syndrome Market's Future: Anticipated Growth and Innovations from 2026 to 2036
The myelodysplastic syndrome market is set for significant growth from 2026 to 2036 due to rising patient awareness and innovative therapies revolutionizing treatment options.
third-news.com
September 15, 2026 at 2:52 PM
l2plabs.bsky.social
Community-Acquired Bacterial Pneumonia Market Poised for Expansion During the Forecast Period (2026-2036) Amid Rising Antimicrobial Resistance and Therapeutic Advances | DelveInsight
The community-acquired bacterial pneumonia market is poised for continued growth, driven by the substantial global disease burden, increasing hospitalization rates, an aging population, rising prevalence of comorbidities, and the growing challenge of antimicrobial resistance....
dlvr.it
September 7, 2026 at 2:32 PM
newsen.bsky.social
The Rise of Emerging Therapies in Osteosarcoma Treatment by 2036#United_States#Las_Vegas#Cancer_Treatment#DelveInsight#Osteosarcoma
The Rise of Emerging Therapies in Osteosarcoma Treatment by 2036
Osteosarcoma market is set to grow significantly by 2036, driven by the introduction of eight promising therapies aimed at improving treatment outcomes for patients.
third-news.com
September 3, 2026 at 2:59 PM
l2plabs.bsky.social
Osteosarcoma Market is Set to Rise by 2036 as 8 Emerging Therapies Set to Drive Future Growth | DelveInsight
The osteosarcoma treatment pipeline is gradually expanding, with emerging therapies such as OST-HER2 (OS Therapies), DANYELZA (naxitamab-gqgk; SERB Pharmaceutical), Vactosertib (MedPacto), Risvutatug rezetecan (GSK), Olaparib with Ceralaserti (AstraZeneca), OMO-103 (Peptomyc),...
dlvr.it
September 3, 2026 at 2:32 PM
l2plabs.bsky.social
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight
The autoimmune uveitis market is poised for steady growth, driven by the increasing recognition and diagnosis of non-infectious uveitis, the need for steroid-sparing therapies, and continued advances in targeted immunomodulatory treatments. Growth is expected to accelerate as emerging...
dlvr.it
September 2, 2026 at 2:34 PM
l2plabs.bsky.social
Musculoskeletal Pain Market Poised for Transformation During the Forecast Period (2026-2036) as Novel Therapies and Non-Opioid Approaches Reshape Treatment | DelveInsight
The musculoskeletal pain market is poised for steady growth, driven by the rising global burden of osteoarthritis, chronic low back pain, neck pain, and other musculoskeletal disorders. Additionally, the emergence of novel therapeutics and potential disease-modifying therapies such as...
dlvr.it
August 31, 2026 at 2:32 PM
cenksidar.bsky.social
🌐 Watching: Biotech firms face a second-order data market as blood biomarkers grow

A GlobeNewswire release via DelveInsight forecasts roughly 9% annu…

🔗 atlas360.news/en/news/biot...

📩 atlas360.news/en/bulten
August 27, 2026 at 10:46 PM
l2plabs.bsky.social
Liver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight
The liver cirrhosis market is expected to witness steady growth over the coming years, driven by the rising prevalence of chronic liver diseases, including hepatitis B, hepatitis C, alcohol-associated liver disease, and MASLD. In addition, a robust pipeline of novel therapies such as...
dlvr.it
August 24, 2026 at 2:32 PM
l2plabs.bsky.social
Radiotherapy-Induced Oral Mucositis Market Set for Strong Growth Through 2036, Driven by Emerging Therapies and Rising Cancer Burden | DelveInsight
The radiotherapy-induced oral mucositis market is expected to witness significant growth due to the increasing incidence of head and neck cancers and the expanding use of radiotherapy as a standard treatment modality. Rising awareness of supportive cancer care, coupled with the...
dlvr.it
August 23, 2026 at 10:53 AM
l2plabs.bsky.social
Hypertrophic Cardiomyopathy Market Set for Transformation Over the Next Decade with the Emergence of Targeted Cardiac Therapies Beyond Conventional Beta-blockers, Calcium Channel Blockers, and Antiarrhythmic Agents | DelveInsight
The hypertrophic cardiomyopathy market is expected to witness significant growth, driven by increasing disease awareness, improved diagnosis rates, and the emergence of targeted disease-modifying therapies including Sotagliflozin (ZYNQUISTA) (Lexicon Pharmaceuticals), Ninerafaxstat...
dlvr.it
August 17, 2026 at 2:34 PM
l2plabs.bsky.social
Bronchiectasis Market is Expected to Surge at a CAGR of 15% by 2036, Owing to the Launch of DPP1/CatC Inhibitors, Therapeutic Phage Cocktails, Nebulized Mucoactive Agents, and Other Novel Mechanisms | DelveInsight
The bronchiectasis market is poised for significant growth, supported by rising disease awareness, advances in diagnostic technologies, and a considerable unmet need for effective long-term treatment options. Additionally, the emergence of a robust pipeline of innovative therapies...
dlvr.it
August 13, 2026 at 2:32 PM
newsen.bsky.social
CAR T-Cell Therapy: A Revolutionary Shift in Acute Lymphoblastic Leukemia Treatment Prospects#USA#Las_Vegas#DelveInsight#CAR_T-cell_Therapy#Acute_Lymphoblastic_Leukemia
CAR T-Cell Therapy: A Revolutionary Shift in Acute Lymphoblastic Leukemia Treatment Prospects
The CAR T-Cell Therapy market for Acute Lymphoblastic Leukemia is projected to witness robust growth fueled by emerging treatments and an expanding pipeline through 2036.
third-news.com
August 12, 2026 at 4:07 PM
l2plabs.bsky.social
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia Market to Grow Significantly at a CAGR of 6.8% During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Pipeline | DelveInsight
The dynamics of CAR T-cell therapy in ALL in the market are anticipated to change in the coming years owing to improvements in research and development activities for efficient treatment options to be available in the market. The launch of emerging therapies such as Lasme-cel (UCART22)...
dlvr.it
August 12, 2026 at 2:32 PM
newsen.bsky.social
Vascular Dementia Market Growth Forecast: An Insight into Emerging Therapies and Trends#United_States#Las_Vegas#DelveInsight#Emerging_Therapies#Vascular_Dementia
Vascular Dementia Market Growth Forecast: An Insight into Emerging Therapies and Trends
The vascular dementia market is projected to grow at a rate of 4.5% up to 2036, spurred by rising prevalence. Discover new treatments and market dynamics.
third-news.com
August 11, 2026 at 3:31 PM
newsen.bsky.social
Predicted Growth in Major Depressive Disorder Market Driven by New Antidepressant Innovations#United_States#Las_Vegas#DelveInsight#Major_Depressive_Disorder#antidepressants
Predicted Growth in Major Depressive Disorder Market Driven by New Antidepressant Innovations
The Major Depressive Disorder market is evolving rapidly with new antidepressants expected to transform treatment landscapes from 2026 to 2036.
third-news.com
August 10, 2026 at 2:34 PM
l2plabs.bsky.social
Major Depressive Disorder Market is Predicted to Grow During the Forecast Period (2026-2036) as Novel Antidepressants are Expected to Enter the Market | DelveInsight
The major depressive disorder market is experiencing a significant transformation as rapid-acting therapies with novel mechanisms of action complement conventional SSRIs and SNRIs. Recent treatment approvals have broadened therapeutic choices for patients with TRD and those who do not...
dlvr.it
August 10, 2026 at 2:33 PM
l2plabs.bsky.social
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
The Alzheimer's disease market dynamics are anticipated to change due to the expected launch of emerging therapies, such as Masupirdinea (Suven Life Sciences), Trontinemabb (Roche), Buntanetap (Annovis bio), Masitinib (AB Science), Remternetug (Eli Lilly), AUVELITY (AXS-05) (Axsome...
dlvr.it
August 6, 2026 at 2:33 PM
nfbot.bsky.social
Neurofibromatosis Type 2 Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight - openPR.com
Neurofibromatosis Type 2 Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight - openPR.com
News update via NF Bot
news.google.com
August 5, 2026 at 9:32 PM
l2plabs.bsky.social
Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
The dementia-related psychosis market is anticipated to increase during the forecast period (2026–2036), owing to the rising burden of dementia, the emergence of novel therapies such as ACP-204 (Remlifanserin) (Acadia Pharmaceuticals), Xanomeline–trospium chloride (COBENFY) (Bristol Myers...
dlvr.it
August 3, 2026 at 2:35 PM
l2plabs.bsky.social
Graves Ophthalmopathy Market Expected to Witness Rapid Expansion at a CAGR of 9% During the Forecast Period (2026-2036), Driven by the Recent Approval of Viridian's LUMVOA and the Launch of Emerging Therapies | DelveInsight
The Graves' ophthalmopathy market is expected to witness steady growth over the coming years, driven by the rising prevalence of autoimmune thyroid disorders, improved disease awareness, and earlier diagnosis. Additionally, the recent approval of LUMVOA has heightened competition in the...
dlvr.it
July 29, 2026 at 2:34 PM
newsen.bsky.social
Innovative Therapies Transforming the Food Allergy Treatment Landscape#None#food_allergy#DelveInsight#therapies
Innovative Therapies Transforming the Food Allergy Treatment Landscape
The food allergy treatment sector is witnessing rapid growth, with promising new therapies on the horizon, changing the lives of affected individuals.
third-news.com
July 27, 2026 at 2:33 PM
l2plabs.bsky.social
Food Allergy Market on the Rise: 5 Emerging Therapies to Watch | DelveInsight
The food allergy market landscape is advancing through a robust clinical pipeline, with key programs being developed by companies such as DBV Technologies (Viaskin [DBV712] Peanut Patch), Novartis (Remibrutinib), Aravax (PVX108), ALK-Abelló (Sublingual Immunotherapy Tablet), InnoUp Farma...
dlvr.it
July 27, 2026 at 2:32 PM
l2plabs.bsky.social
Acute Pain Market Forecast Signals Accelerated Growth at a CAGR of 12% During the Forecast Period (2026-2036), Driven by Novel Non-Opioid Therapies and Expanding Treatment Options | DelveInsight
The acute pain market is witnessing steady growth, driven by the increasing adoption of multimodal pain management approaches, along with growing demand for non-opioid and long-acting analgesics. Additionally, the expected launch of emerging therapies such as Rizatriptan (RizaFilm)...
dlvr.it
July 21, 2026 at 2:32 PM
l2plabs.bsky.social
Degenerative Disc Disease Market to Observe Stupendous Growth at ~19% CAGR by 2036, Due to Launch of Novel Drug Classes Such as Cell Replacement, NF-kappa B Inhibitors, Cartilage Regeneration via TGF-β1 Expression, and Others | DelveInsight
The degenerative disc disease market is witnessing a paradigm shift, transitioning from traditional symptom-focused treatments and surgical procedures toward regenerative and disease-modifying therapies. Emerging pipeline candidates, including SB-01 (Spine Biopharma), IDCT (DiscGenics),...
dlvr.it
July 20, 2026 at 2:32 PM
newsen.bsky.social
Transformative Therapies in the C3 Glomerulopathy Market: Future Trends and Insights#USA#Las_Vegas#DelveInsight#Emerging_Therapies#C3_Glomerulopathy
Transformative Therapies in the C3 Glomerulopathy Market: Future Trends and Insights
Explore the evolving landscape of C3 Glomerulopathy with emerging therapies that promise to revolutionize treatment options, addressing significant unmet needs.
third-news.com
July 16, 2026 at 3:00 PM